CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 16 enrolled
Drug / intervention
GE VScan Access R2 Ultrasound System +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03617419
NCT03617419N/ACompleted

Evaluation of Feasibility and Accuracy of Assisted Fetal Heart Rate (FHR) Feature of the GE Vscan Access R2 Ultrasound System

GE Healthcare·interventional·Posted Aug 6, 2018·Updated Jul 11, 2019

In Brief

A clinical study evaluating GE VScan Access R2 Ultrasound System and GE Corometrics 170 Series Fetal Monitor for Gather Feasibility Data and User Feedback on Use of a Device in Vivo on Pregnant Volunteers in Their 2nd and 3rd Trimester. Completed, enrolled 16 participants across 1 site.

Detailed Summary

This study is being done to evaluate if the Vscan Access R2 Ultrasound System can measure Fetal Heart Rate (FHR) in humans when compared against a reference device (GE Corometrics 170 Series Fetal Monitor), and to gather feedback from device operators on the usability of the device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 6, 2018
Enrollment StartNov 14, 2017
Primary CompletionNov 20, 2017
Study CompletionFeb 26, 2018
TodayJul 2, 2026
Enrollment to primary: 6 daysPosted 7.9 years ago

Interventions

GE VScan Access R2 Ultrasound Systemdevice

A diagnostic ultrasound imaging system manufactured by the study Sponsor.

GE Corometrics 170 Series Fetal Monitordevice

A reference device to record a continuous fetal heart rate.

GE Corometrics 170 Series Fetal Monitordevice

A reference device for verification of scanning the fetal heart.